Stock Screener App
Frei
-
Play Store
App Store
Installieren
Installieren
Light
Dark
DE
anmelden
Beobachtungsliste
Top-Listen
Märkte
Neu
Charts
Kryptos
Branchen
Elite
Marktsimulator
Produkte
CTKB
$6.32
6.76%
0.40
Nachbörslich: 6.35
+0.03 +0.47%
Cytek Biosciences Inc (CTKB)
Indikator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Vollbild-Chart
Überblick
Preisverlauf
Optionskette
Finanzen
Forum
Prognose
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums
2026-09-30
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Periodenlänge
3 Monate
3 Monate
3 Monate
3 Monate
3 Monate
Revenues
10.57%
53.23
48.14
44.14
62.14
52.29
Cost Of Revenue
11.23%
22.02
19.80
22.88
29.26
24.74
Gross Profit
10.11%
31.21
28.34
21.25
32.89
27.55
Operating Expenses
0.28%
39.63
39.74
39.72
38.48
36.74
Research and Development
3.96%
9.36
9.74
9.60
8.96
8.96
Operating Income/Loss
26.11%
-8.42
-11.40
-18.46
-5.59
-9.19
Nonoperating Income/Loss
723.46%
1.52
-0.24
1.09
1.56
1.42
Income Tax Expense/Benefit, Deferred
-
-
-0.18
38.58
-2.63
Income Tax Expense/Benefit
257.48%
-0.81
0.52
1.49
40.05
-2.29
Net Income/Loss
49.85%
-6.10
-12.16
-18.87
-44.08
-5.48
Attributable To Parent
49.85%
-6.10
-12.16
-18.87
-44.08
-5.48
Available To Common Stockholders, Basic
49.85%
-6.10
-12.16
-18.87
-44.08
-5.48
Basic Average Shares
0.69%
130.36
129.46
128.70
0.14
127.55
Diluted Average Shares
0.69%
130.36
129.46
128.70
0.14
127.55
Ähnlich wie CTKB
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
In EDGAR öffnen
|
In Reuters öffnen